EA200700756A1 - Пиримидоны - Google Patents
ПиримидоныInfo
- Publication number
- EA200700756A1 EA200700756A1 EA200700756A EA200700756A EA200700756A1 EA 200700756 A1 EA200700756 A1 EA 200700756A1 EA 200700756 A EA200700756 A EA 200700756A EA 200700756 A EA200700756 A EA 200700756A EA 200700756 A1 EA200700756 A1 EA 200700756A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- integer
- formula
- disease
- halogen
- pirimidony
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
Описываются соединения, представленные формулой (I), их оптически активные изомеры или их фармацевтически приемлемые соли, где в указанной формуле Rпредставляет (C-C)алкил; Rпредставляет атом водорода или подобное; Rпредставляет галоген или подобное; q равен целому числу от 1 до 7; Rпредставляет галоген или подобное; р равен 0 или целому числу от 1 до 5; Rпредставляет (С-С)арил, гетероцикл или подобное; и Х представляет кислород, NH или подобное, которые применяют для профилактики и/или лечения заболевания, вызванного гиперактивностью тау-протеинкиназы 1, такого как нейродегенеративные заболевания (например, болезнь Альцгеймера).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004313115 | 2004-09-29 | ||
PCT/JP2005/018497 WO2006036015A2 (en) | 2004-09-29 | 2005-09-29 | 6- (pyridinyl) -4-pyrimidone derivates as tau protein kinase 1 inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200700756A1 true EA200700756A1 (ru) | 2007-10-26 |
EA013004B1 EA013004B1 (ru) | 2010-02-26 |
Family
ID=35848411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200700756A EA013004B1 (ru) | 2004-09-29 | 2005-09-29 | Производные 6-пиридинил-4-пиримидона в качестве ингибиторов тау-протеинкиназы 1 |
Country Status (25)
Country | Link |
---|---|
US (1) | US8129377B2 (ru) |
EP (3) | EP1805164B9 (ru) |
JP (1) | JP5186213B2 (ru) |
KR (1) | KR20070057931A (ru) |
CN (1) | CN101048397A (ru) |
AR (1) | AR051823A1 (ru) |
AT (1) | ATE499356T1 (ru) |
AU (1) | AU2005288045B2 (ru) |
BR (1) | BRPI0515851A (ru) |
CA (1) | CA2581179A1 (ru) |
CY (1) | CY1112326T1 (ru) |
DE (1) | DE602005026546D1 (ru) |
DK (1) | DK1805164T3 (ru) |
EA (1) | EA013004B1 (ru) |
ES (1) | ES2359071T3 (ru) |
IL (1) | IL182223A0 (ru) |
MX (1) | MX2007003722A (ru) |
NO (1) | NO20072214L (ru) |
NZ (1) | NZ554722A (ru) |
PL (1) | PL1805164T3 (ru) |
PT (1) | PT1805164E (ru) |
SI (1) | SI1805164T1 (ru) |
TW (1) | TWI354669B (ru) |
WO (1) | WO2006036015A2 (ru) |
ZA (1) | ZA200703383B (ru) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR050865A1 (es) * | 2004-09-09 | 2006-11-29 | Sanofi Aventis | Derivados de 2- morfolino-4-pirimidona |
GB0510141D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B3 |
GB0510142D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
TW200740779A (en) | 2005-07-22 | 2007-11-01 | Mitsubishi Pharma Corp | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
TW200813015A (en) * | 2006-03-15 | 2008-03-16 | Mitsubishi Pharma Corp | 2-(cyclic amino)-pyrimidone derivatives |
CA2661334C (en) * | 2006-08-23 | 2011-11-29 | Pfizer Products Inc. | Pyrimidone compounds as gsk-3 inhibitors |
WO2008026046A1 (en) * | 2006-08-30 | 2008-03-06 | Pfizer Products Inc. | Morpholine d3 dopamine antagonists |
AR064660A1 (es) * | 2006-12-26 | 2009-04-15 | Mitsubishi Tanabe Pharma Corp | Derivados de pirimidinona 6-heterociclica 2-sustituida, medicamentos que los contienen y usos para prevenir y/o tratar enfermedades neurodegenerativas entre otras |
JP4691669B2 (ja) | 2007-08-22 | 2011-06-01 | アストラゼネカ・アクチエボラーグ | シクロプロピルアミド誘導体 |
BRPI0816705A2 (pt) * | 2007-09-14 | 2015-03-17 | Mitsubishi Tanabe Pharma Corp | Derivatido de 6-pirimidinil-pirimid-2-ona |
TW201039825A (en) | 2009-02-20 | 2010-11-16 | Astrazeneca Ab | Cyclopropyl amide derivatives 983 |
WO2011019090A1 (en) * | 2009-08-13 | 2011-02-17 | Mitsubishi Tanabe Pharma Corporation | Pyrimidone derivatives used as tau protein kinase 1 inhibitors |
JPWO2011062194A1 (ja) | 2009-11-18 | 2013-04-04 | 武田薬品工業株式会社 | アミノピリジン誘導体 |
US9452980B2 (en) * | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
KR20130002316A (ko) | 2010-02-18 | 2013-01-07 | 아스트라제네카 아베 | 시클로프로필 벤즈아미드 유도체의 신규 결정질 형태 |
WO2011143057A1 (en) | 2010-05-11 | 2011-11-17 | Merck Sharp & Dohme Corp. | Novel prolylcarboxypeptidase inhibitors |
EP2928473B1 (en) * | 2012-12-07 | 2017-06-28 | Merck Sharp & Dohme Corp. | Regioselective n-2 arylation of indazoles |
WO2018200517A1 (en) | 2017-04-24 | 2018-11-01 | Tesaro, Inc. | Methods of manufacturing of niraparib |
CN117143079A (zh) * | 2018-11-06 | 2023-12-01 | 上海奕拓医药科技有限责任公司 | 一种螺芳环化合物及其应用 |
CN111704611B (zh) * | 2019-07-25 | 2022-01-14 | 上海凌达生物医药有限公司 | 一类芳基螺环类shp2抑制剂化合物、制备方法和用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR023052A1 (es) * | 1998-09-25 | 2002-09-04 | Mitsuharu Yoshimura Milton | Derivados de pirimidona |
EP1136482A1 (en) | 2000-03-23 | 2001-09-26 | Sanofi-Synthelabo | 2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors |
EP1136483A1 (en) * | 2000-03-23 | 2001-09-26 | Sanofi-Synthelabo | 2-[Piperazinyl]pyrimidone derivatives |
TWI265164B (en) | 2001-09-21 | 2006-11-01 | Mitsubishi Pharma Corp | 3-substituted-4-pyrimidone derivatives |
PL368816A1 (en) | 2001-09-21 | 2005-04-04 | Mitsubishi Pharma Corporation | 3-substituted-4-pyrimidone derivatives |
EP1454908B1 (en) * | 2003-03-07 | 2008-02-27 | Sanofi-Aventis | Substituted pyridinyl-2-(diaza-bicyclo-alkyl)-pyrimidinone derivatives |
TWI357408B (en) * | 2003-03-26 | 2012-02-01 | Mitsubishi Tanabe Pharma Corp | 3-substituted-4-pyrimidone derivatives |
-
2005
- 2005-09-29 KR KR1020077008236A patent/KR20070057931A/ko not_active Application Discontinuation
- 2005-09-29 EP EP05790292A patent/EP1805164B9/en not_active Not-in-force
- 2005-09-29 SI SI200531256T patent/SI1805164T1/sl unknown
- 2005-09-29 DE DE602005026546T patent/DE602005026546D1/de active Active
- 2005-09-29 EP EP10010448A patent/EP2261224A3/en not_active Withdrawn
- 2005-09-29 CA CA002581179A patent/CA2581179A1/en not_active Abandoned
- 2005-09-29 DK DK05790292.6T patent/DK1805164T3/da active
- 2005-09-29 ZA ZA200703383A patent/ZA200703383B/xx unknown
- 2005-09-29 AU AU2005288045A patent/AU2005288045B2/en not_active Ceased
- 2005-09-29 WO PCT/JP2005/018497 patent/WO2006036015A2/en active Application Filing
- 2005-09-29 NZ NZ554722A patent/NZ554722A/en not_active IP Right Cessation
- 2005-09-29 CN CNA2005800330250A patent/CN101048397A/zh active Pending
- 2005-09-29 TW TW094134059A patent/TWI354669B/zh not_active IP Right Cessation
- 2005-09-29 JP JP2007533116A patent/JP5186213B2/ja not_active Expired - Fee Related
- 2005-09-29 BR BRPI0515851-6A patent/BRPI0515851A/pt not_active IP Right Cessation
- 2005-09-29 PL PL05790292T patent/PL1805164T3/pl unknown
- 2005-09-29 EP EP10010450A patent/EP2266969A3/en not_active Withdrawn
- 2005-09-29 ES ES05790292T patent/ES2359071T3/es active Active
- 2005-09-29 AR ARP050104099A patent/AR051823A1/es not_active Application Discontinuation
- 2005-09-29 US US11/576,062 patent/US8129377B2/en not_active Expired - Fee Related
- 2005-09-29 MX MX2007003722A patent/MX2007003722A/es active IP Right Grant
- 2005-09-29 AT AT05790292T patent/ATE499356T1/de active
- 2005-09-29 EA EA200700756A patent/EA013004B1/ru not_active IP Right Cessation
- 2005-09-29 PT PT05790292T patent/PT1805164E/pt unknown
-
2007
- 2007-03-27 IL IL182223A patent/IL182223A0/en unknown
- 2007-04-27 NO NO20072214A patent/NO20072214L/no not_active Application Discontinuation
-
2011
- 2011-05-04 CY CY20111100427T patent/CY1112326T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700756A1 (ru) | Пиримидоны | |
EA200700572A1 (ru) | Соединение 2-морфолино-4-пиримидона | |
EA200870358A1 (ru) | 2-(циклический амино) пиримидоновые производные в качестве ингибиторов tpk1 | |
NO20064726L (no) | Imidazolforbindelser for behandling av neurodegenerative forstyrrelser | |
EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
MX2007006896A (es) | Fenil-metanonas bi- y triciclicas sustituidas como inhibidores del transportador 1 de glicina (glyt-1) para el tratamiento de la enfermedad de alzheimer. | |
NO20070606L (no) | Inhibitorer av IAP | |
EA200970637A1 (ru) | 2-замещенные-6-гетероциклилпроизводные пиримидона в качестве ингибиторов тау-протеинкиназы | |
TW200635585A (en) | Monocyclic substituted methanones | |
DE602004028150D1 (de) | Aminopyrazolderivate als gsk-3-inhibitoren | |
ATE307810T1 (de) | Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren | |
EA200401114A3 (ru) | Замещённые гидроксиэтиламины | |
EA201070366A1 (ru) | 3-метил-2-((2s)-2-(4-(3-метил-1,2,4-оксадиазол-5-ил)фенил)морфолино)-6-(пиримидин-4-ил)пиримидин-4(3н)-он в качестве ингибитора тау-протеинкиназы | |
ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
WO2006055434A3 (en) | Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease | |
EA200501311A1 (ru) | ПРОИЗВОДНЫЕ ЗАМЕЩЁННОГО 8-ПЕРФТОРАЛКИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА | |
ATE409480T1 (de) | Pyrazoloä3,4-büpyridin-6-one als gsk-3 inhibitoren | |
EA201070367A1 (ru) | Производное 6-пиримидинилпиримид-4-она | |
DE602006014022D1 (de) | 5-substituierte indol-2-carbonsäureamidderivate | |
EA200600760A1 (ru) | Новые соединения фенилпиридилпиперазина, способ их получения и фармацевтические композиции, содержащие их | |
ATE524171T1 (de) | Verwendung von 2-(2-nitro-4- trifluormethylbenzoyl)-1,3-cyclohexandion bei der behandlung der parkinson-krankheit | |
TW200635911A (en) | Sulfanyl substituted phenyl methanones | |
EA200700322A1 (ru) | Оксазолидиноны, содержащие оксиндолы, в качестве антибактериальных агентов | |
ATE391122T1 (de) | 4 ((2,4-dichloro-5-methoxyphenyl)amino)-6-alkoxy- 7-ethynyl-3-quinolinecarbonitrile zur behandlung von ischämie | |
TH96043A (th) | สารประกอบไพริมิโดน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM RU |